← Back to all signals
RESEARCH PAPER ANALYSIS

Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study.

AI interpretation is pending for this paper.

Open original publication →
PMID42744956
JournalSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Publication Date2026-09-15
Ingested2026-09-17 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: With advancements in lymphoma treatment leading to improved survival rates, the time burden associated with cancer care has emerged as a significant concern. Time toxicity can disrupt daily life and impact treatment decisions; however, lymphoma-specific evidence regarding patients' subjective experiences remains limited. This study aimed to investigate the experiences of time toxicity and the coping strategies employed by young and middle-aged lymphoma patients in China. METHODS: This descriptive qualitative study took place from June to December 2025 in the haematology department of a tertiary hospital in Hangzhou, China. We employed purposive sampling with maximum variation to recruit patients aged 18-50 years who were undergoing lymphoma treatment. The study was informed by Time-Geography Theory. Data collection involved face-to-face semi-structured interviews, and the data were analysed using conventional content analysis. RESULTS: The study involved fifteen participants, revealing five interconnected themes: (1) the multidimensional time burden driven by treatment; (2) the disruption of social roles and restructuring of daily life rhythms; (3) healthcare mobility constrained by time and space; (4) emotional distress associated with time toxicity; and (5) multilevel coping strategies for managing time toxicity. Time toxicity manifested not only as the cumulative time spent on healthcare activities but also as disruptions to daily routines, role functioning, healthcare mobility, and psychological well-being. Participants reported substantial time burdens due to frequent hospital visits, prolonged waiting times, and complex care pathways, particularly for those requiring cross-city care. Despite these challenges, patients employed various coping strategies, including active time management, Health-oriented self-management, cognitive adjustment, and family support. CONCLUSIONS: Time toxicity in young and middle-aged lymphoma patients is a multidimensional and contextually embedded experience shaped by the interaction between healthcare demands and everyday life. These findings highlight the importance of considering patients' temporal and spatial circumstances when coordinating lymphoma care and developing supportive interventions.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Impact of Transport Media on IL-33 Levels in Samples From Patients With Viral Respiratory Infections. Journal of immunology research 58.2 2 Eosinophilic Fasciitis in Children: A Case Report. Cureus 51.4 3 Sporadic Burkitt Lymphoma Presenting as Refractory Iron-Deficiency Anemia in a Three-Year-Old Boy: A Case Report. Cureus 49.52 4 Measurable residual disease detected by next-generation sequencing in T-cell acute lymphoblastic leukemia. Nature communications 61.2 5 Postoperative antibiotic continuation does not reduce infectious complications after elective pediatric ostomy reversal: A NSQIP Pediatric analysis. Journal of pediatric surgery 68.5 6 A Phase Ib Case Series Using Bortezomib With Chemotherapy in Atypical Teratoid/Rhabdoid Tumors. Cancer medicine 84.54 7 Metabolic reprogramming-related drug resistance in osteosarcoma: from molecular mechanisms to therapeutic translation. Frontiers in molecular biosciences 86.25 8 Pembrolizumab-induced type-1 diabetes mellitus: clinical characteristics, therapeutic strategies, and prognosis from a retrospective analysis of 43 published cases. Frontiers in endocrinology 65.74 9 Feeding and swallowing function and dysphagia risk in children with posterior fossa tumors: a preliminary Italian cohort study. Frontiers in oncology 67.0 10 The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov. Frontiers in pediatrics 73.16 11 Lipidomic analysis of isolated lipid droplets reveals potential metabolic pathway differences between medulloblastoma subgroups. Frontiers in neuroscience 56.0 12 Case Report: Selumetinib as a neoadjuvant treatment for the removal of a PN. Frontiers in pediatrics 50.74 13 PACSIN2 regulates mercaptopurine cytotoxicity and cellular biomechanics through Rac1 modulation in intestinal epithelial cells. Frontiers in pharmacology 58.42 14 Enhancing Communication and Consent Using 3-D Printed Models With a Pediatric Dental Patient Presenting With Odontogenic Keratocysts Associated With Gorlin Syndrome: A Case Report. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 47.5 15 Respiratory Syncytial Virus-Associated Disease in Children Receiving Intensive Care. JAMA network open 64.5 16 A comprehensive survey of genetic variants in neuroblastoma. Journal, genetic engineering & biotechnology 59.9 17 The role of CHAMP1 in chromatin-mediated DNA damage repair. DNA repair 60.6 18 Vertigo and dizziness syndromes in children and adolescents: Clinical presentation and diagnostic pathway. Developmental medicine and child neurology 62.0 19 Antidepressant and antipsychotic prescriptions among 21 605 English survivors of childhood cancer: a population-based cohort. Journal of the National Cancer Institute 59.9 20 Prolonged Headache in a 13-Year-Old Girl With Acute Lymphoblastic Leukemia: A Case of Possible Neuroinflammatory Complication Responsive to Intravenous Immunoglobulin. Clinical case reports 47.8 21 Assessment of Potentially Toxic and Essential Metals in Commonly Consumed Tomato Ketchup Brands from Local Markets in Faisalabad, Pakistan, and Associated Health Risks. Biological trace element research 57.5 22 MRI-based radiomics for prognosis of non-midline, pediatric high-grade gliomas. Journal of neuro-oncology 81.0 23 Mapping an Overlooked Spiral of Trauma-Exposure to Sexual Abuse and Psycho-Spiritual Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis. Cancer nursing 79.0 24 Establishing the First National Fanconi Anemia Registry in Iran: Clinical and Epidemiological Insights From 116 Patients. Pediatric blood & cancer 61.5 25 New and emerging somatostatin therapies for neuroendocrine tumors: "what is in the pipeline". Expert opinion on pharmacotherapy 69.1 26 Infection profile and risk factors for adverse outcomes in children with febrile neutropenia: a single-center study from Northwestern India. Pediatric hematology and oncology 62.0 27 Cryptic PML::RARA With Concurrent RUNX1::RUNX1T1 in an Adolescent With Acute Promyelocytic Leukemia. Pediatric blood & cancer 47.5 28 Body Composition and Physical Activity are Associated With Prediabetes in Childhood, Adolescent, and Young Adult Cancer and Hematopoietic Cell Transplantation Survivors. Pediatric blood & cancer 54.0 29 Early Palliative Care Is Feasible and Acceptable in Pediatric Neuro-Oncology. Pediatric blood & cancer 58.7 30 Transverse Myelitis and Guillain-Barré Syndrome in Pediatric Lymphoid Malignancies: An International Retrospective Study. Pediatric blood & cancer 65.1 31 Cost-Effectiveness of Early Empirical Antibiotic Cessation in Pediatric High-Risk Febrile Neutropenia. Pediatric blood & cancer 62.9 32 Factors associated with early death among children and adolescents with cancer in Brazil: a nationwide registry-based study. Pediatric hematology and oncology 70.3
PATIENT-FRIENDLY SUMMARY

Experiences and coping strategies of time toxicity in young and middle-aged patients with lymphoma: a descriptive qualitative study.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic